Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes
| Autor: | Chinmay S. Marathe, Tongzhi Wu, Christopher K. Rayner, Helen L. Checklin, Paul Kuo, Michelle J. Bound, Sony S. Thazhath, Jessica Chang, Michael Horowitz, Rachael S. Rigda, Karen L. Jones, Joan Khoo |
|---|---|
| Přispěvatelé: | Thazhath, SS, Marathe, CS, Wu, T, Chang, J, Khoo, J, Kuo, P, Checklin, HL, Bound, MJ, Rigda, RS, Horowitz, M, Jones, KL, Rayner, CK |
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Acute effects
Blood Glucose Male Time Factors Endocrinology Diabetes and Metabolism Type 2 diabetes 030204 cardiovascular system & hematology 0302 clinical medicine Glucose infusion Heart Rate South Australia Insulin Infusions Intravenous Cross-Over Studies Middle Aged Treatment Outcome Female Cardiology and Cardiovascular Medicine medicine.drug Signal Transduction medicine.medical_specialty postprandial hypotension Duodenum exenatide glucagon-like peptide-1 receptor agonist 030209 endocrinology & metabolism Glucagon-Like Peptide-1 Receptor 03 medical and health sciences Double-Blind Method Internal medicine Diabetes mellitus Heart rate Internal Medicine medicine Humans Hypoglycemic Agents Arterial Pressure Glucagon-like peptide 1 receptor business.industry Venoms medicine.disease Endocrinology Blood pressure Glucose Diabetes Mellitus Type 2 ‘gut–heart axis’ Exenatide business Gastrointestinal Motility Peptides |
| Popis: | Aim:To evaluate the effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate during an intraduodenal glucose infusion in type 2 diabetes.Methods:Nine subjects with type 2 diabetes were randomised to receive intravenous exenatide or saline control in a crossover design. Glucose (3 kcal min−1) was infused via an intraduodenal manometry catheter for 60 min. Blood pressure, heart rate, and the frequency and amplitude of duodenal pressure waves were measured at regular intervals. Gastrointestinal symptoms were monitored using 100 mm visual analogue scales.Results:During intraduodenal glucose infusion (0–60 min), diastolic ( p(0–60) = 0.03) and mean arterial ( p(0–60) = 0.03) blood pressures and heart rate ( p(0–60) = 0.06; p(0–120) = 0.03)) were higher with exenatide compared to placebo. The increase in the area under the curve for diastolic blood pressure and mean arterial blood pressure was related directly to the suppression of the duodenal motility index with exenatide compared to control ( p = 0.007 and 0.04, respectively).Conclusion:In type 2 diabetes, intravenous exenatide increases mean arterial blood pressure and heart rate during an intraduodenal glucose infusion, supporting the need for further research with exenatide for its potential use in postprandial hypotension. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|